Rebekah R. White

8.4k total citations · 1 hit paper
108 papers, 6.3k citations indexed

About

Rebekah R. White is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rebekah R. White has authored 108 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 31 papers in Surgery and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rebekah R. White's work include Pancreatic and Hepatic Oncology Research (50 papers), Advanced biosensing and bioanalysis techniques (15 papers) and Pancreatitis Pathology and Treatment (14 papers). Rebekah R. White is often cited by papers focused on Pancreatic and Hepatic Oncology Research (50 papers), Advanced biosensing and bioanalysis techniques (15 papers) and Pancreatitis Pathology and Treatment (14 papers). Rebekah R. White collaborates with scholars based in United States, Switzerland and Canada. Rebekah R. White's co-authors include Bruce A. Sullenger, Douglas S. Tyler, Bryan M. Clary, Shahid M. Nimjee, Christopher P. Rusconi, Theodore N. Pappas, Richard C. Becker, Partha Ray, Herbert I. Hurwitz and Timothy P. Wakeman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Rebekah R. White

103 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aptamers as Therapeutics

2017 445 citations Rebekah R. White, Bruce A. Sullenger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebekah R. White United States	47	3.4k	2.3k	1.5k	1.3k	965	108	6.3k
Gustavo Baretton Germany	46	3.0k 0.9×	2.5k 1.1×	1.4k 0.9×	1.9k 1.5×	1.5k 1.6×	312	7.3k
Eun Kyung Choi South Korea	41	1.9k 0.6×	1.7k 0.7×	1.1k 0.8×	1.8k 1.4×	772 0.8×	259	6.2k
Rex C. Bentley United States	49	1.6k 0.5×	2.7k 1.2×	1.8k 1.2×	860 0.7×	1.2k 1.3×	163	8.5k
Alain C. Mita United States	46	3.4k 1.0×	3.7k 1.6×	1.3k 0.8×	1.8k 1.5×	989 1.0×	210	8.1k
Ferdinand Hofstaedter Germany	42	1.9k 0.6×	2.3k 1.0×	2.0k 1.3×	1.1k 0.9×	726 0.8×	131	6.1k
P Stieber Germany	49	3.2k 0.9×	2.6k 1.1×	958 0.6×	1.4k 1.1×	1.8k 1.9×	214	7.1k
Ruth L. Katz United States	46	3.5k 1.0×	3.3k 1.4×	2.1k 1.4×	2.1k 1.7×	2.1k 2.1×	212	9.3k
Christopher Poremba Germany	54	2.5k 0.8×	3.0k 1.3×	1.3k 0.9×	2.2k 1.7×	1.8k 1.9×	166	7.7k
Vincent T.H.B.M. Smit Netherlands	56	3.8k 1.1×	2.7k 1.2×	1.5k 1.0×	1.8k 1.4×	2.7k 2.8×	200	12.0k
Melissa P. Upton United States	41	1.5k 0.4×	1.9k 0.8×	1.6k 1.1×	1.9k 1.5×	1.1k 1.1×	119	5.7k

Countries citing papers authored by Rebekah R. White

Since Specialization

Citations

This map shows the geographic impact of Rebekah R. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebekah R. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebekah R. White more than expected).

Fields of papers citing papers by Rebekah R. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebekah R. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebekah R. White. The network helps show where Rebekah R. White may publish in the future.

Co-authorship network of co-authors of Rebekah R. White

This figure shows the co-authorship network connecting the top 25 collaborators of Rebekah R. White. A scholar is included among the top collaborators of Rebekah R. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebekah R. White. Rebekah R. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Robert C.G., Rebekah R. White, Malcolm M. Bilimoria, et al.. (2024). Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study. Cancers. 16(23). 3894–3894. 4 indexed citations

Narayanan, Jayanth S. Shankara, et al.. (2024). Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment. Molecular Cancer Therapeutics. 23(11). 1597–1612. 2 indexed citations

Capacio, Benedict R., Diego Vicente, Yujia Liu, et al.. (2023). Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model.. Journal of Clinical Oncology. 41(4_suppl). 729–729.

Narayanan, Jayanth S. Shankara, Tomoko Hayashi, Sara McArdle, et al.. (2023). Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. Journal for ImmunoTherapy of Cancer. 11(1). e006133–e006133. 17 indexed citations

White, Rebekah R.. (2023). Work-Life Integration for Academic Surgeons. JAMA Surgery. 158(12). 1235–1235. 1 indexed citations

Narayanan, Jayanth S. Shankara, et al.. (2023). Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer – A review. Heliyon. 10(1). e23551–e23551.

Banerjee, Sudeep, Hyunho Yoon, Mayra Yebra, et al.. (2020). Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 19(5). 1173–1182. 11 indexed citations

Bolli, Martin, et al.. (2020). Role of lymphadenectomy in resectable pancreatic cancer. Langenbeck s Archives of Surgery. 405(7). 889–902. 10 indexed citations

Duncan, David, et al.. (2020). Subcapsular hematoma resulting in hepatic ischemia as a complication of necrotizing pancreatitis. SHILAP Revista de lepidopterología. 15(4). 316–320.

10.

Narayanan, Jayanth S. Shankara, Partha Ray, Tomoko Hayashi, et al.. (2019). Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Cancer Immunology Research. 7(10). 1714–1726. 86 indexed citations

11.

Nussbaum, Daniel P., Kara Penne, Paul J. Speicher, et al.. (2014). The role of clinical care pathways: an experience with distal pancreatectomy. Journal of Surgical Research. 190(1). 64–71. 12 indexed citations

12.

Shah, Anand, K. Chao, Truls Østbye, et al.. (2013). Trends in Racial Disparities in Pancreatic Cancer Surgery. Journal of Gastrointestinal Surgery. 17(11). 1897–1906. 60 indexed citations

13.

Lampson, Benjamin L., Brooke B. Ancrile, Meghan M. Morrison, et al.. (2012). Targeting eNOS in Pancreatic Cancer. Cancer Research. 72(17). 4472–4482. 56 indexed citations

14.

Worni, Mathias, Anthony W. Castleberry, Bryan M. Clary, et al.. (2012). Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease. JAMA Surgery. 148(4). 331–331. 55 indexed citations

15.

Rialon, Kristy L. & Rebekah R. White. (2011). Aptamers: Potential Applications to Pancreatic Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 11(5). 434–441. 4 indexed citations

16.

Barbas, Andrew S., Jing Mi, Bryan M. Clary, & Rebekah R. White. (2010). Aptamer Applications for Targeted Cancer Therapy. Future Oncology. 6(7). 1117–1126. 73 indexed citations

17.

Ceppa, Eugene P., Sebastián G. de la Fuente, Srinevas K. Reddy, et al.. (2009). Defining Criteria for Selective Operative Management of Pancreatic Cystic Lesions: Does Size Really Matter?. Journal of Gastrointestinal Surgery. 14(2). 236–244. 15 indexed citations

18.

Barbas, Andrew S. & Rebekah R. White. (2009). The development and testing of aptamers for cancer.. PubMed. 10(6). 572–8. 17 indexed citations

19.

Sarraf‐Yazdi, Shiva, Jing Mi, Benjamin J. Moeller, et al.. (2008). Inhibition of In Vivo Tumor Angiogenesis and Growth Via Systemic Delivery of an Angiopoietin 2-Specific RNA Aptamer. Journal of Surgical Research. 146(1). 16–23. 41 indexed citations

20.

Sullenger, Bruce A., Rebekah R. White, & Christopher P. Rusconi. (2003). Therapeutic Aptamers and Antidotes: A Novel Approach to Safer Drug Design. PubMed. 217–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact